AP-1 function and regulation

Current Opinion in Cell Biology

Volumn 9, Issue 2, 1997, Pages 240-246

  Karin, Michael ^a   Liu, Zheng Gang ^a   Zandi, Ebrahim ^a  

^a San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR AP 1;

CELL PROLIFERATION; ONCOGENE C FOS; ONCOGENE C JUN; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

EID: 0030906497     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(97)80068-3     Document Type: Article

References (83)

1. Vogt PK, Bos TJ: jun: oncogene and transcription factor. Adv Cancer Res 1990, 55:1-35.
2. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991, 1072:129-157.
3. Ziff EB: Transcription factors: a new family gathers at the cAMP response site. Trends Genet 1990, 6:69-72.
4. Kouzarides T, Ziff EB: The role of the leucine zipper in the fos-jun interaction. Nature 1988, 336:646-651.
5. Smeal T, Angel P, Meek J, Karin M: Different requirements for formation of Jun:Jun and Jun:Fos complexes. Genes Dev 1989, 3:2091-2100.
6. Zerial M, Toschi L, Ryseck RP, Schuermann M, Muller R, Bravo R: The product of a novel growth factor activated gene, fosB, interacts with JUN proteins enhancing their DNA binding activity. EMBO J 1989, 8:805-813.
7. Matsui M, Tokuhara M, Konuma Y, Nomura, Ishizaki R: Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation. Oncogene 1990, 5:249-255.
8. Hai T, Curran T: Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 1991, 88:3720-3724.
9. Hsu JC, Laz T, Mohn KL, Taub R: Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver. Proc Natl Acad Sci USA 1991, 88:3511-3515.
10. Dorsey MJ, Tae HJ, Sollenberger KG, Mascarenhas NT, Johansen LM, Taparowsky EJ: B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogens 1995, 11:2255-2265.
11. Nishizawa M, Kataoka K, Goto N, Fujiwara KT, Kawai S: v-maf, a viral oncogene that encodes a "leucine zipper" motif. Proc Natl Acad Sci USA 1989, 86:7711-7715.
12. Swaroop A, Xu JZ, Pawar H, Jackson A, Skolnick C, Agarwal N: A conserved retina-specific gene encodes a basic motif/leucine zipper domain. Proc Natl Acad Sci USA 1992, 89:266-270.
13. Kerppola TK, Curran T: Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun. Oncogene 1996, 9:675-684.
14. Fujiwara KT, Kataoka K, Nishizawa M: Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain. Oncogene 1993, 8:2371-2380.
15. Kataoka K, Fujiwara KT, Noda M, Nishizawa M: MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Mol Cell Biol 1994, 14:7581-7591.
16. Kataoka K, lgarashi K, Itoh K, Fujiwara KT, Noda M, Yamamoto M, Nishizawa M: Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Mol Cell Biol 1995, 15:2180-2190.
17. Hilberg K, Aguzzi A, Howwlles N, Wagner EF: c-Jun is essential for normal mouse development and hepatogenesis. Nature 1993, 365:179-181.
18. Johnson RS, Van Lingen B, Papaioannou VE, Spiegelman BM: A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev 1993, 7:1309-1317.
19. Johnson RS, Spiegelman BM, Papaionnou V: Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 1992, 71:577-586.
20. Brown JR, Ye H, Bronson RT, Dikkes P, Greenberg ME: A defect in nurturing in mice lacking the immediate early gene fosB. Cell 1996, 86:297-309. This paper shows that FosB plays a role in the nurturing behavior of mice.
21. Reimold AM, Grusby MJ, Kosaras B, Fries JWU, Mori R, Maniwa S, Clauss IM, Collins T, Sidman RL, Glimcher MJ, Glimcher LH: Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 1996, 379:262-265. The authors of this paper show the role of ATF2 in mouse development.
22. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995, 270:16483-16486.
23. Treier M, Staszewski LM, Bohman D: Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 1994, 78:787-798.
24. Tsurumi C, Ishida N, Tamura T, Kakaizuka A, Nishida E, Ilumura E, Kishimoto T, Inagaki M, Okazaki K, Sagata N et al.: Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol Cell Biol 1995, 15:5682-5687.
25. Musti AM, Treier M, Bohmann D: Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 1997, 275:400-402.
26. Hibi M, Lin A, Smeal T, Minden A, Karin M: Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993, 7:2135-2148.
27. Smeal T, Hibi M, Karin M: Altering the specificity of signal transduction cascades: positive regulation of c-Jun transcriptional activity by protein kinase A. EMBO J 1994, 13:6006-6010.
28. Piechaczyk M, Blanchard J-M: c-fos protoncogene regulation and function. Crit Rev Oncol Hematol 1994, 17:93-131.
29. Treisman R: The serum response element. Trends Biochem 1992, 17:423-426.
30. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 1991, 252:1427-1430.
31. Hummler E, Cole TJ, Blendy JA, Ganss R, Aguzzi A, Achmid W, Beermann F, Schutz G: Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc Natl Acad Sci USA 1994, 91:5647-5651.
32. Blendy JA, Kaestner KH, Weinbauer GF, Nieschlag E, Schutz G: Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature 1996, 380:162-165. The authors of this paper show the role of CREM in spermatogenesis.
33. Darnell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
34. Darnell JE Jr: The JAK-STAT pathway: summary of initial studies and recent advances. Recent Prog Horm Res 1996, 51:391-403.
35. Treisman R: Ternary complex factors: growth factor regulated transcriptional activators. Curr Opin Genet Dev 1994, 4:96-101.
36. Gille H, Sharrocks A, Shaw P: Phosphorylation of p62TCF by MAP kinase stimulates ternary complex formation at c-Fos promoter. Nature 1992, 358:414-417.
37. Marais R, Wynne J, Treisman R: The SRF accessory protein Elk-1 contains a growth factor regulated transcription domain. Cell 1993, 73:381-393.
38. Hipskind RA, Buscher D, Nordheim A, Baccarini M: Ras/MAP kinase-dependent and -independent signalling pathways target distinct ternary complex factors. Genes Dev 1994, 8:1803-1816.
39. Price MA, Rogers AE, Treisman R: Comparative analysis of the ternary complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET). EMBO J 1995, 14:2589-2601.
40. Devary Y, Gottleib RA, Karin M: Rapid and preferential activation of the c-Jun gene during the mammalian UV response. Mol Cell Biol 1991, 11:2804-2811.
41. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ: Integration of MAP kinase signal transduction pathways at the serum response element. Science 1995, 269:403-407.
42. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995, 270:7420-7426.
43. Cavigelli M, Dolfi F, Claret FX, Karin M: Induction of c-fos expression through JNK mediated TCF/Elk-1 phosphorylation. EMBO J 1995, 14:5957-5964.
44. Raingeaud J, Whitmarsh AJ, Barret T, Derijard B, Davis RJ: MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal. Mol Cell Biol 1996, 16:1247-1255.
45. Hazzalin CA, Cano E, Cueda A, Barratt MS, Cohen P, Mahadevan LC: p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF2 phosphorylation are insufficient. Curr Biol 1996, 6:1028-1031.
46. Gruda MC, Vanamsterdam J, Rizzo CA, Durham SK, Lira A, Bravo R: Expression of FosB during mouse development - normal development of FosB knockout mice. Oncogene 1996, 12:2177-2185.
47. Wang ZQ, Liang J, Schellander K, Wagner EF, Grigoriadis AE: c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos. Cancer Res 1995, 55:6244-6251.
48. Van Dam H, Duyndam M, Rottier R, Bosch A, De Vries-Smits L, Herrlich P, Zantema A, Angel P, Van der Eb A: Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J 1993, 12:479-487.
49. Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ: JNK1: a protein kinase stimulated by UV light and H-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76:1020-1028.
50. Gupta S, Campbell D, Deijard B, Davis RJ: Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995. 267:389-393.
51. Van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P: ATF2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO 1995, 14:1798-1811.
52. Dérijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ: Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 1995, 267:682-685.
53. Kallunki T, Deng T, Hibi M, Karin M: c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 1996, 87:929-939. This paper demonstrates a new mechanism for regulation of transcriptional activity. It is shown that c-Jun can recruit JNK to facilitate the phosphorylation of dimerizing partners that lack a kinase-docking site of their own.
54. Kallunki T, Su B, Tsigelny I, Sluss HK, Dérijard B, Moore G, Davis R, Karin M: JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 1994, 8:2996-3007.
55. Arias J, Alberts AS, Brindle P, Claret F-X, Smeal T, Karin M, Fremisco J, Montminy M: Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 1994, 370:226-228.
56. Kwok RP, Lundblad JR, Chrivia JC, Richards JP, Bachinger HR Brennan RG, Roberts SGE, Green MR, Goodman RH: Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994, 370:223-226.
57. Bannister AJ, Oehler T, Wilhelm D, Angel P, Kouzarides T: Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 1995, 11:2509-2514.
58. Arany Z, Sellers WR, Livingston DM, Eckner R: E1 A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 1994, 77:799-800.
59. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman RA, Rose DW, Glass CK, Rosenfeld MG: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996, 85:403-414. This paper shows that CBP may be the common cofactor that participates in the transcriptional activation of nuclear receptors and AP-1.
60. Saatcioglu F, Claret FX, Karin M: Negative transcriptional regulation by nuclear receptors. Semin Cell Biol 1994, 5:347-359.
61. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M: Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990, 62:1205-1215.
62. Chakracarti D, LaMorte VJ, Melson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans R: Role of CBP/p300 in nuclear receptor signaling. Nature 1996, 383:99-103.
63. Claret FX, Hibi M, Dhut S, Toda T, Karin M: A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 1996, 383:453-457. This paper describes a new group of transcriptional coactivators for AP-1.
64. + positively regulates pap1(+) dependent transcription and is implicated in the maintenance of chromosome structure. J Cell Sci 1995, 108:569-579.
65. Min W, Ghosh S, Lengyel P: The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kB, c-Fos, and c-Jun activities. Mol Cell Biol 1996, 16:359-368.
66. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implication in tissue kinetics. Brit J Cancer 1972, 26:239-257.
67. Ellis RE, Yua J, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 1991, 7:663-698.
68. Korsmeyer SJ: Regulators of cell death. Trends Genet 1995, 11:101-105.
69. Johnson R, Spiegelman B, Hanahan D, Wisdom R: Cellular transformation and malignancy induced by ras require c-jun. Mol Cell Biol 1996, 16:4504-4511.
70. Colotta F, Polentarutti N, Sironi M, Mantovani A: Expression and involvement of c-fos and c-jun protooncogene in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 1992, 267:18278-18283.
71. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan J: Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993, 363:166-169.
72. Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M, Rubin LL: A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 1995, 14:927-939. This paper suggests that dominant-negative mutant c-Jun blocks NGF withdrawal induced apoptosis. Overexpression of wild-type c-Jun results in apoptosis in sympathetic neurons.
73. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer KMJ, Szabo E, Zon LI, Kyriakis JM et al. : Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 1996, 380:75-79.
74. Gajate C, Alonso MT, Schimmang T, Mollinedo F: C-Fos is not essential for apoptosis. Biochem Biophys Res Commun 1996, 218:267-272.
75. Roffler-Tarlov S, Jeremy J, Brown G, Tarlov E, Stolarov J, Chapman DL, Alexiou M, Papaioannou VE: Programmed cell death in the absence of c-Fos and c-Jun. Development 1996, 122:1-9. The authors of this paper show that the programmed cell death that occurs during development can take place normally in the absence of c-Fos and c-Jun.
76. Lenczowski JM, Dominguez L, Eder A, King LB, Zacharchuk CM, Ashwell JD: Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol 1997, 17:170-181. AP-1 is not activated during Fas-induced apoptosis and JNK activation is delayed and not required in this process.
77. Liu Z-G, Hsu H, Goeddel DV, Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death. Cell 1996, 87:565-576. TRAF2 (TNF receptor associated factor 2) activates JNK and AP-1 but not apoptosis, and FADD (Fas-associated death domain protein) induces apoptosis but not AP-1 and JNK activation. Activation of AP-1 and JNK is not linked to TNF-induced apoptosis.
78. Raff MC: Social control on cell survival and cell death. Nature 1992, 356:397-400.
79. Martin SJ: Apoptosis: suicide, execution or murder? Trends Cell Biol 1993, 3:141-144.
80. King LB, Ashwell JD: Signaling for death of lymphoid cells. Curr Opin Immunol 1993, 5:368-373.
81. Brenner DA, Ohara M, Angel P, Chojkier M, Karin M: Prolonged activation of jun and collagenase genes by tumor necrosis factor-a. Nature 1989, 337:661-663.
82. Schreiber M, Baumann B, Cotton M, Angel P, Wanger EF: Fos is an essential component of the mammalian UV response. EMBO J 1995, 14:5338-5349. This paper shows that c-Fos provides protection against UVC treatment.
83. Aronheim A, Zandi E, Hennemann H, Elledge SJ, Karin M: Isolation of an AP-1 repressor by a novel method for detecting protein-protein interaction. Mol Cell Biol 1997, in press.